Capillary electrophoresis (CE) has supported DNA, RNA, and oligonucleotide analysis for decades. Today, it is helping biopharmaceutical laboratories gain deeper insight into nucleic acid quality, from starting materials to final products.

Join this webinar to explore how CE is being adapted to profile impurities in messenger RNA (mRNA) and oligonucleotides, and how it can help assess plasmid quality in workflows used to produce viral vectors, including adeno-associated virus (AAV) particles, and mRNA drug targets.

In this session, you will learn how CE can support:

• Analysis of DNA, RNA, and oligonucleotides in biopharmaceutical quality control workflows
• Impurity profiling for mRNA and oligonucleotide development
• Plasmid quality assessment for viral vector and mRNA production workflows

Register to learn how CE can help strengthen analytical confidence across nucleic acid development and manufacturing.